SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • September 20th, 2022 • GSK PLC • Pharmaceutical preparations • New York
THIS SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of September 16, 2022, by and between Theravance Biopharma, Inc., a Cayman Islands exempted company (“Company”), and GSK Finance (No.3) plc, a public company limited by shares registered under the laws of England and Wales (“Seller”).
